FDA guidance on prophylactic DNA vaccines: Analysis and recommendations

Dennis M. Klinman, Sven Klaschik, Debra Tross, Hidekazu Shirota, Folkert Steinhagen

Research output: Contribution to journalComment/debatepeer-review

42 Citations (Scopus)

Abstract

The FDA has been regulating the conduct of prophylactic DNA vaccine trials in the US for nearly 15 years. This work describes the evolution of FDA policy over that period, the status of current regulatory guidance, and provides recommendations for further changes to facilitate development in this field.

Original languageEnglish
Pages (from-to)2801-2805
Number of pages5
JournalVaccine
Volume28
Issue number16
DOIs
Publication statusPublished - 2010 Apr 1
Externally publishedYes

Keywords

  • Clinical trials
  • DNA vaccines
  • Guidance

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'FDA guidance on prophylactic DNA vaccines: Analysis and recommendations'. Together they form a unique fingerprint.

Cite this